DOI: 10.33917/es-1.193.2024.132-137

The article describes the competitive strategy of a pharmaceutical company in the context of digitalization of society. It describes how the patient’s voice assistant allows the company to influence levels of demand, receive information about the behavior patterns of the target audience and increases the brand’s points of contact with the target audience. The technology of developing a voice assistant for the healthcare industry is presented, and mechanisms of influence on the target audience are described.

References:

1. Kovtyukh G.S. Osnovnye tendentsii razvitiya farmatsevticheskogo rynka v Rossii [Main Trends in the Development of the Pharmaceutical Market in Russia] Lechebnoe delo, 2023, no 2, pp. 134–140, DOI 10.24412/2071-5315-2023-12888, EDN GGLUIQ

2. Arzhanova K.A. Sovremennye PR-tekhnologii prodvizheniya kompanii [Modern PR Technologies for Company Promotion]. Kompetentnost’, 2020, no 5, pp. 30–35, available at: https://cyberleninka.ru/article/n/sovremennye-pr-tehnologii-prodvizheniya-kompanii-1

3. Vinichuk O.Yu. Sovremennye metody prodvizheniya farmatsevticheskikh kompaniy na regional’nykh farmatsevticheskikh rynkakh v usloviyakh tsifrovizatsii biznesa [Elektronnyy resurs]. Vestnik evraziyskoy nauki, 2023, vol. 15, no 3, available at: https://esj.today/PDF/77ECVN323.pdf

4. Prentice С., Loureiro S.M., Guerreiro J. Engaging with intelligent voice assistants for wellbeing and brand attachment. Journal of Brand Management, 2023, no 30, pp. 449–460. 10.1057/s41262-023-00321-0 Engaging with intelligent voice assistants for wellbeing and brand attachment.

5. McLean G., Osei-Frimpong K., Barhorst J. Alexa, do voice assistants influence consumer brand engagement? — Examining the role of AI powered voice assistants in influencing consumer brand engagement. Journal of Business Research, 2021, no 124, pp. 312–328. 10.1016/j.jbusres.2020.11.045.

6. Zuenkova Yu.A., Bogdanovich S.T. Beyond the Pill — strategiya marketinga otnosheniy na farmatsevticheskom rynke [Beyond the Pill —Relationship Marketing Strategy in the Pharmaceutical Market]. Mikroekonomika, 2023, no 5, pp. 39–47, available at: https://doi.org/10.33917/mic-5.112.2023.39–47

7. Andriyanova E.A. Sotsial’noe doverie v meditsine: vozmozhnosti onlayn-kommunikatsii: Nauka kak obshchestvennoe blago: Sb. Nauchnykh statey Vtorogo mezhdunarodnogo kongressa Russkogo obshchestva istorii i filosofii nauki. Sankt-Peterburg, 27–29 noyabrya 2020 g. [Social Trust in Medicine: Online Communication Opportunities: Science as a Public Good: Sat. Scientific Articles of the Second International Congress of the Russian Society for History and Philosophy of Science. St. Petersburg, November 27–29, 2020]. Sankt-Peterburgskiy gosudarstvennyy universitet; Russkoe obshchestvo istorii i filosofii nauki, vol. 5. Moscow, Mezhregional’naya obshchestvennaya organizatsiya “Russkoe obshchestvo istorii i filosofii nauki’, 2020, pp. 90–93, EDN ZWEESO

8. Porter M. Konkurentnaya strategiya. Metodika analiza otrasley i konkurentov. Moscow, Al’pina Pablisher, 2015, 456 p.

DOI: 10.33917/mic-5.112.2023.39-47

The purpose of the study was to describe one of the forms of implementation of the relationship marketing strategy characteristic of the pharmaceutical industry – the Beyond the Pill strategy. The article describes the history of the strategy, the main forms of its implementation, defines the role of the Beyond the pill strategy in the era of digitalization and the transition of healthcare to a value-oriented approach, and provides an example of the implementation of the strategy in the Russian market. The features and conditions of the implementation of the relationship marketing strategy in the pharmaceutical market are highlighted. A system of balanced indicators is proposed to assess the effectiveness of the implementation of the strategy.

References: 

1. Fleck Leonardm. Controlling Healthcare Costs: Just Cost Effectiveness or «Just» Cost Effectiveness? Cambridge Quarterly of Healthcare Ethics. Cambridge University Press. 2018;27(2):271–83.
2. OECD (2023), Health spending (indicator). URL: https://www.oecd.org/els/health-systems/health-data.htm doi: 10.1787/8643de7e-en
3. Kovacs R., Powell-Jackson T, Kristensen S., Singh N, Borghi J. How are pay-for-performance schemes in healthcare designed in low- and middle-income countries? Typology and systematic literature review. BMC Health Serv Res. 2020:7;20(1):291. doi: 10.1186/s12913-020-05075-y
4. Ananthakrishnan A., Luz A.C.G., KC S. et al. How can health technology assessment support our response to public health emergencies? Health Res Policy Sys. 2022;20:124 (2022). https://doi.org/10.1186/s12961-022-00925-z
5. Wenzel, Meike & Henne, Nathalie & Zollner, Y. Beyond the pill: The move towards value-added services in the pharmaceutical industry. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing. 2014;14: 91-98.
6. Porter ME, Teisberg EO. Redefining Health Care: Creating Value-Based Competition on Results. Harvard Business School Press, 2006.
7. Marsh K., Caro J., Hamed A., Zaiser E. Amplifying Each Patient’s Voice: A Systematic Review of Multi-criteria Decision Analyses Involving Patients. Appl Health Econ Health Policy. 2017;15(2):155-162. doi: 10.1007/s40258-016-0299-1. PMID: 27928659.
8. Khurana, Atul & Rastogi, Rahul & Gamperl, Hans-Joachim. Patient Support Program in Pharmacovigilance: Foster Patient Confidence and Compliance. International Journal of Medical, Health, Biomedical, Bioengineering and Pharmaceutical Engineering. 2017;11:148-151.
9. Krishnamoorthy R. Environmental, social, and governance (ESG) investing: Doing good to do well. Open J Soc Sci. 2021;9:189–97.
10. Marcus A. Koch. Pharmaceutical Market Access: current state of affairs and key challenges – results of the Market Access Launch Excellence Inventory (MALEI). Journal of Market Access & Health Policy. 2015;3:C. 1-10. DOI: 10.3402/jmahp.v3.29679
11. Ersoy Yusuf & Tehci Ali. Relationship marketing orientation in healthcare organisations with the AHP method: Internal and external customer perspective, 2023.
12. Shillington, Alicia & Ganjuli, Arijit & Clewell, Jerry. The impact of patient support programs on adherence, clinical, humanistic, and economic patient outcomes: A targeted systematic review. Patient Preference and Adherence, 2016.
13. Brixner, D.I., Rubin, D.T., Mease, P.J., Mittal, M., Liu, H.H., Davis, M., Ganguli, A.X., & Fendrick, A.M. Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending. Journal of managed care & specialty pharmacy. 2019;25(7):770-779.
14. Landwehr Konstantin. Digital Transformation in the Pharmaceutical Industry – From Products to Services «Beyond the Pill», 2015.